This content is machine translated Autoimmune Liver Diseases Innovative Treatment Approaches for PBC, PSC, and AIH: What’s New? PPAR agonists as second-line therapy have proven effective in primary biliary cholangitis (PBC) not only in clinical trials but also in real-world settings, as recent research findings show. In primary...…
View Post 3 min This content is machine translated Risk of osteoporosis in autoimmune liver diseases Always determine bone density in PBC, PSC and AIH Studies show that primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH) are associated with a significantly increased risk of developing osteopenia or osteoporosis. For this reason,...…
View Post 4 min This content is machine translated Guideline recommendations Update on autoimmune liver diseases The guidelines of the European Association for the Study of the Liver (EASL) provide recommendations for the treatment of PSC, PBC and AIH. However, these are not always up to…
View Post 6 min This content is machine translated 20th Continuing Education Conference of the College of Family Medicine (KHM), Lucerne Bitter images: Gallbladder disease “BitterSweet” was the theme of the 20th KHM Continuing Education Conference 2018. In a keynote lecture, Prof. Stephan Vavricka, MD, and Regula Capaul, MD, presented five pathologies of the gallbladder…
